Deutsche Bank Downgrades Apogee Therapeutics Inc (APGE) to Hold
Tweet
Share
E-mailGet Alerts APGE Hot Sheet
Price: $134.26 --0%
Rating Summary:
6 Buy, 12 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 11 | New: 2
Rating Summary:
6 Buy, 12 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 11 | New: 2
Join SI Premium – FREE
Deutsche Bank analyst David Hoang downgraded Apogee Therapeutics Inc (NASDAQ: APGE) from Buy to Hold with a price target of $135.00 (from $116.00).
For an analyst ratings summary and ratings history on Apogee Therapeutics Inc click here. For more ratings news on Apogee Therapeutics Inc click here.
Shares of Apogee Therapeutics Inc closed at $90.38 yesterday.
You May Also Be Interested In
- Truist Securities Downgrades Flywire (FLYW) to Hold
- Admiral Group Plc. (ADM:LN) (AMIGY) PT Raised to GBP31 at JPMorgan
- Repsol SA (REP:SM) (REPYY) PT Raised to EUR25 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
